FDA Inspection 1187256 — Andre Frecehette, M.D.
The FDA completed an inspection of Andre Frecehette, M.D. on October 21, 2022 in Quebec. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 21, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Quebec (Canada)
Additional Details
Clinical Investigator (CI)